Zymosan‐Treated SKG Mice: Assessing Effects of Systemic Inflammation on the Temporomandibular Joint
Oral Diseases · 2025
DOI: 10.1111/odi.15242 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2025. Verfasst von Kaito Uryu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, Kobe, Japan. Hauptthemen laut MEDLINE: Zymosan, Temporomandibular Joint, Temporomandibular Joint Disorders, Inflammation. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science (JSPS), KAKENHI, Grant-in-Aid for Scientific Research (C), Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Objectives
The effects of systemic inflammation on the temporomandibular joint (TMJ) are poorly understood. This study aimed to establish a mouse model to study the effects of systemic inflammation on the TMJ. Materials and Methods SKG mice, a BALB/c strain with spontaneous onset of rheumatoid arthritis‐like symptoms due to a spontaneous point mutation (W163C) in the gene encoding the SH2 domain of ZAP‐70, were treated with zymosan (β‐1,3‐glucan). Synovitis, bone erosion, and cartilage damage in the TMJ were evaluated using established scores for animal models of inflammatory arthritis. Myeloperoxidase‐positive areas and numbers of tartrate‐resistant acid phosphatase (TRAP)‐positive cells were compared between naive and zymosan‐treated SKG mice. Correlations between TMJ inflammation scores and clinical scores for extremities were also assessed.
Results
There were significant differences in TMJ inflammation scores, including synovitis, bone erosion, and cartilage damage, between naive and high‐dose zymosan‐treated mice. There were significant differences in myeloperoxidase‐positive areas and numbers of TRAP‐positive cells between naive and zymosan‐treated mice. There were significant correlations between TMJ inflammation scores and clinical scores for extremities.
Conclusions
Systemic administration of zymosan efficiently induces TMJ inflammation in SKG mice. Zymosan‐treated SKG mice offer a useful tool to investigate the effects of systemic inflammation on the TMJ.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
- Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan.
- Division of Pathology, Department of Pathology, Kobe University Graduate School of Medicine, Kobe, Japan.
ORCID-Profile: Manabu Shigeoka, Masaya Akashi
Förderung
- Japan Society for the Promotion of Science (JSPS), KAKENHI, Grant-in-Aid for Scientific Research (C)
- Japan Society for the Promotion of Science
Zitieren
APA
Uryu, K., Kakei, Y., Sendo, S., Goto, I., Akashi, K., Nishimura, K., Shirai, T., Hirota, J., Takeda, D., Shigeoka, M., Kimoto, A., Hasegawa, T., Saegusa, J., & Akashi, M. (2025). Zymosan‐Treated SKG Mice: Assessing Effects of Systemic Inflammation on the Temporomandibular Joint. Oral Diseases. https://doi.org/10.1111/odi.15242
Vancouver
Uryu K, Kakei Y, Sendo S, Goto I, Akashi K, Nishimura K, et al. Zymosan‐Treated SKG Mice: Assessing Effects of Systemic Inflammation on the Temporomandibular Joint. Oral Diseases. 2025. doi:10.1111/odi.15242
BibTeX
@article{Uryu2025,
author = {Uryu, Kaito and Kakei, Yasumasa and Sendo, Sho and Goto, Ikuko and Akashi, Kengo and Nishimura, Keisuke and Shirai, Tatsuya and Hirota, Junya and Takeda, Daisuke and Shigeoka, Manabu and Kimoto, Akira and Hasegawa, Takumi and Saegusa, Jun and Akashi, Masaya},
title = {Zymosan‐Treated SKG Mice: Assessing Effects of Systemic Inflammation on the Temporomandibular Joint},
journal = {Oral Diseases},
year = {2025},
doi = {10.1111/odi.15242}
}
EUVIMED